When the cycle of chronic idiopathic urticaria (CIU) symptoms persists despite H1 antihistamine treatment, consider XOLAIR earlier. XOLAIR was studied in patients who experienced itch and hives for ≥8 consecutive weeks prior to enrollment despite the use of H1 antihistamines. 23,24

XOLAIR has been shown to reduce mean weekly itch severity and mean weekly hive count scores in appropriate CIU patients 12 years and older uncontrolled on H1 antihistamines. 10 Use the links below to learn more:

Mean Weekly Itch Data 
Mean Weekly Hive Data 
Complete Relief Data 

See additional information for patient baseline characteristics. Please see full safety information.

Mean Weekly Itch Data

Mean Weekly Hive Data

Complete Relief Data

Patient Baseline Characteristics